Class information for:
Level 1: BIFUNCTIONAL PEPTIDE INHIBITOR//TYKESON MS//BATF2

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
32328 110 39.7 89%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
3225 1510 MACROPHAGE MIGRATION INHIBITORY FACTOR//MIF//MACROPHAGE MIGRATION INHIBITORY FACTOR MIF

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 BIFUNCTIONAL PEPTIDE INHIBITOR Author keyword 9 83% 5% 5
2 TYKESON MS Address 6 53% 7% 8
3 BATF2 Author keyword 3 100% 3% 3
4 TYKESON MULTIPLE SCLEROSIS Address 3 60% 3% 3
5 NEUROIMMUNOL TYKESON MULTIPLE SCLEROSIS Address 2 67% 2% 2
6 RD31 Address 2 67% 2% 2
7 BATF Author keyword 2 33% 4% 4
8 PROTEOLIPID PEPTIDE Author keyword 1 100% 2% 2
9 RECOMBINANT T CELL RECEPTOR LIGAND RTL Author keyword 1 100% 2% 2
10 SOLUBLE ANTIGEN ARRAY Author keyword 1 100% 2% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 BIFUNCTIONAL PEPTIDE INHIBITOR 9 83% 5% 5 Search BIFUNCTIONAL+PEPTIDE+INHIBITOR Search BIFUNCTIONAL+PEPTIDE+INHIBITOR
2 BATF2 3 100% 3% 3 Search BATF2 Search BATF2
3 BATF 2 33% 4% 4 Search BATF Search BATF
4 PROTEOLIPID PEPTIDE 1 100% 2% 2 Search PROTEOLIPID+PEPTIDE Search PROTEOLIPID+PEPTIDE
5 RECOMBINANT T CELL RECEPTOR LIGAND RTL 1 100% 2% 2 Search RECOMBINANT+T+CELL+RECEPTOR+LIGAND+RTL Search RECOMBINANT+T+CELL+RECEPTOR+LIGAND+RTL
6 SOLUBLE ANTIGEN ARRAY 1 100% 2% 2 Search SOLUBLE+ANTIGEN+ARRAY Search SOLUBLE+ANTIGEN+ARRAY
7 MESOPOROUS WOLLASTONITE 1 50% 1% 1 Search MESOPOROUS+WOLLASTONITE Search MESOPOROUS+WOLLASTONITE
8 NANO BIOGLASS 1 50% 1% 1 Search NANO+BIOGLASS Search NANO+BIOGLASS
9 PARTIAL MHC CLASS II CONSTRUCTS 1 50% 1% 1 Search PARTIAL+MHC+CLASS+II+CONSTRUCTS Search PARTIAL+MHC+CLASS+II+CONSTRUCTS
10 PEPTIDE PROTEIN CONJUGATES 1 50% 1% 1 Search PEPTIDE+PROTEIN+CONJUGATES Search PEPTIDE+PROTEIN+CONJUGATES

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 CYTOKINE SWITCH 8 75% 5% 6
2 CELL RECEPTOR LIGANDS 4 75% 3% 3
3 BIFUNCTIONAL PEPTIDE INHIBITOR 3 100% 3% 3
4 PROMISING THERAPEUTIC APPROACH 3 100% 3% 3
5 BATF 2 67% 2% 2
6 B ATF 2 36% 4% 4
7 RECOMBINANT TCR LIGANDS 1 100% 2% 2
8 SARI SUPPRESSOR 1 100% 2% 2
9 BOUND SINGLE PEPTIDES 1 15% 5% 6
10 ANTIGEN SPECIFIC SUPPRESSION 1 13% 5% 5

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Peptide-MHC-based nanovaccines for the treatment of autoimmunity: a "one size fits all" approach? 2011 6 57 28%
Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks 2013 35 77 9%
The use of flow cytometry to assess a novel drug efficacy in multiple sclerosis 2015 0 41 27%
Peptides and peptidomimetics as immunomodulators 2014 2 125 3%
Antigen-specific blocking of CD4-Specific immunological synapse formation using BPI and current therapies for autoimmune diseases 2012 3 304 2%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 TYKESON MS 6 53% 7.3% 8
2 TYKESON MULTIPLE SCLEROSIS 3 60% 2.7% 3
3 NEUROIMMUNOL TYKESON MULTIPLE SCLEROSIS 2 67% 1.8% 2
4 RD31 2 67% 1.8% 2
5 ANESTHESIOL PERIOPERT MED 1 50% 0.9% 1
6 ORTHOPAED SURG CHEM MAT BIOMOL ENGN 1 50% 0.9% 1
7 PATHOLOGISTS 1 50% 0.9% 1
8 NEUROIMMUNOL RD 31 1 20% 2.7% 3
9 UHS 46 0 33% 0.9% 1
10 BLOOD PREPARAT 0 25% 0.9% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000139652 EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS//MYELIN OLIGODENDROCYTE GLYCOPROTEIN//EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
2 0.0000093402 STROKE ASSOCIATED PNEUMONIA//RECOMBINANT T CELL RECEPTOR LIGAND//STROKE INDUCED IMMUNODEPRESSION
3 0.0000075970 SECRETION INHIBITION//RNF13//PROTEASE ASSOCIATED DOMAIN
4 0.0000056937 PEPTIDE MHC//PEPTIDE MAJOR HISTOCOMPATIBILITY COMPLEX//PROT CRYSTALLOG UNIT
5 0.0000051726 INVARIANT CHAIN//HLA DM//ANTIGEN PROCESSING
6 0.0000046991 IMMUNOLOGICAL SYNAPSE//LYMPHOCYTE INTERACT//PROGRAM MOL PATHOGENESIS
7 0.0000045884 MULTIMERIC LIGANDS//NDP ALPHA MSH//DISSOCIATION ENHANCED LANTHANIDE FLUOROIMMUNOASSAY
8 0.0000042431 FRA 1//JUN//V JUN
9 0.0000041974 CSF CEREBROSPINAL FLUID//SOLUBLE VASCULAR CELL ADHESION MOLECULE 1 SVCAM 1//INTRAVENOUS METHYLPREDNISOLONE
10 0.0000041409 HUNAN GREEN PACKAGING PLICAT BIOL NAN//JOURNAL OF BIOMEDICAL NANOTECHNOLOGY//STATE BIOELECT